Literature DB >> 19565363

Primary gastrointestinal non-Hodgkin's lymphoma: clinicopathological and prognostic analysis.

Tong Wang1, Wei Gui, Quanliang Shen.   

Abstract

The objective is to investigate the association between pathological type and clinical features, response to treatment and prognosis of primary gastrointestinal Non-Hodgkin's lymphoma (PGINHL). The clinicopathologic features, response to treatment and survival of 124 patients with PGINHL, were investigated retrospectively. Ninety-one patients were treated with surgery, most of which included combined therapy, while 32 patients received chemotherapy alone. Survival analysis was performed by Kaplan-Meier and Cox regression method. The most common immunophenotype was B-cell subtype. In 115 (92.7%) patients of B-cell lymphoma, mucosa-associated lymphoid tissue lymphoma (MALToma) and diffuse large B-cell lymphoma (DLBCL) were 55 and 50 patients, respectively. The patients of two pathological types had different clinical features including stage, B symptoms, sites of tumor, distant involvement, International Prognosis Index Score, size of tumor, and response to treatment. Both overall survival curve and multiple Cox regression analysis indicated that pathological type was statistically significant. The pathological subtype of PGINHL was an important prognostic factor. The patients with MALToma appear to have more favorable prognosis than those with DLBCL.

Entities:  

Mesh:

Year:  2009        PMID: 19565363     DOI: 10.1007/s12032-009-9265-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  21 in total

1.  Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma--results of the prospective German Multicenter Study GIT NHL 01/92.

Authors:  P Koch; F del Valle; W E Berdel; N A Willich; B Reers; W Hiddemann; B Grothaus-Pinke; G Reinartz; J Brockmann; A Temmesfeld; R Schmitz; C Rübe; A Probst; G Jaenke; H Bodenstein; A Junker; C Pott; J Schultze; A Heinecke; R Parwaresch; M Tiemann
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

2.  Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92.

Authors:  P Koch; F del Valle; W E Berdel; N A Willich; B Reers; W Hiddemann; B Grothaus-Pinke; G Reinartz; J Brockmann; A Temmesfeld; R Schmitz; C Rübe; A Probst; G Jaenke; H Bodenstein; A Junker; C Pott; J Schultze; A Heinecke; R Parwaresch; M Tiemann
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

Review 3.  Low-grade MALT lymphoma of the stomach: a review of treatment options.

Authors:  N R Schechter; J Yahalom
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-03-15       Impact factor: 7.038

4.  Ileal mucosa-associated lymphoid tissue lymphoma showing several ulcer scars detected using double-balloon endoscopy.

Authors:  N Yoshida; N Wakabayashi; K Nomura; H Konishi; H Yamamoto; S Mitsufuji; K Kataoka; M Taniwaki; H Yamagishi; T Okanoue
Journal:  Endoscopy       Date:  2004-11       Impact factor: 10.093

5.  Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial.

Authors:  Agustin Avilés; María Jesús Nambo; Natividad Neri; Alejandra Talavera; Sergio Cleto
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

6.  Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends.

Authors:  Shotaro Nakamura; Takayuki Matsumoto; Mitsuo Iida; Takashi Yao; Masazumi Tsuneyoshi
Journal:  Cancer       Date:  2003-05-15       Impact factor: 6.860

7.  Mucosa-associated lymphoid tissue (MALT) lymphoma of the jejunum: an elusive cause of recurrent upper gastrointestinal bleeding.

Authors:  C S Chim; F Loong; G C Ooi
Journal:  Leuk Lymphoma       Date:  2004-02

8.  Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment.

Authors:  Jeeyun Lee; Won Seog Kim; Kihyun Kim; Young Hyeh Ko; Jae Jun Kim; Young Ho Kim; Ho Kyung Chun; Woo Yong Lee; Joon Oh Park; Chul Won Jung; Young-Hyuck Im; Mark H Lee; Won Ki Kang; Keunchil Park
Journal:  Leuk Lymphoma       Date:  2004-02

9.  Primary colonic lymphoma.

Authors:  Quintín H Gonzalez; Martin J Heslin; Andrea Dávila-Cervantes; Javier Alvarez-Tostado; Antonio Espinosa de los Monteros; Gregg Shore; Selwyn M Vickers
Journal:  Am Surg       Date:  2008-03       Impact factor: 0.688

10.  Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry.

Authors:  K A Gurney; R A Cartwright; E A Gilman
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  9 in total

1.  MALT Lymphoma of the Gastric Remnant After Roux-en-Y Gastric Bypass.

Authors:  Ahmed Jawad; Allan H Bar; Demetri Merianos; Jing Zhou
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  The Lymphocyte-Monocyte Ratio and the Platelet-Lymphocyte Ratio at Diagnosis as Independent Prognostic Factors in Primary Gastrointestinal Diffuse Large B Cell Lymphoma.

Authors:  Pan Zhao; Li Zang; Xiaoying Zhang; Yafang Chen; Hongliang Yang; Haifeng Zhao; Yong Yu; Yafei Wang; Yizhuo Zhang; Xiaofang Wang
Journal:  Indian J Hematol Blood Transfus       Date:  2016-08-29       Impact factor: 0.900

3.  Overexpression of DNA methyltransferase 1 as a negative independent prognostic factor in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab.

Authors:  Haifeng Zhao; L E Zhang; Shanqi Guo; Tian Yuan; Bing Xia; Lianyu Zhang; Yizhuo Zhang
Journal:  Oncol Lett       Date:  2015-03-13       Impact factor: 2.967

4.  Increased MALAT1 expression predicts poor prognosis in primary gastrointestinal diffuse large B-cell lymphoma.

Authors:  Zhengzi Qian; Leiyuan Chen; Xinyuan Wang; Yutian Kan; Yafei Wang; Yong Yu; Xiaofang Wang; Zhigang Zhao; Hongliang Yang; Peng Ge; Tingting Ding; Qiongli Zhai; Haifeng Zhao
Journal:  Clin Exp Med       Date:  2021-08-24       Impact factor: 3.984

5.  Clinicopathological characteristics and prognostic factors of primary gastrointestinal lymphoma: a 22-year experience from South China.

Authors:  Minrui Li; Shenghong Zhang; Fang Gu; Weiwei Xiao; Jiayan Yao; Kang Chao; Minhu Chen; Juan Li; Bihui Zhong
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

6.  Systemic lupus erythematosus presenting with eosinophilic enteritis: a case report.

Authors:  Mehrnaz Asadi Gharabaghi; Pejman Abdollahi; Mohammad Kalany; Masoud Sotoudeh
Journal:  J Med Case Rep       Date:  2011-06-25

7.  Mantle cell lymphoma presenting with severe upper gastrointestinal bleeding: A case report.

Authors:  Khaled Ali; Mhd Baraa Habib; Ferial Alloush; Mohamed A Yassin
Journal:  Medicine (Baltimore)       Date:  2022-06-10       Impact factor: 1.817

8.  Primary Gastrointestinal Lymphoma: A Retrospective Multicenter Clinical Study of 415 Cases in Chinese Province of Guangdong and a Systematic Review Containing 5075 Chinese Patients.

Authors:  Yinting Chen; Yanzhu Chen; Shaojie Chen; Lili Wu; Lishu Xu; Guoda Lian; Kege Yang; Yaqing Li; Linjuan Zeng; Kaihong Huang
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

9.  miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphoma.

Authors:  Xinyuan Wang; Yutian Kan; Leiyuan Chen; Peng Ge; Tingting Ding; Qiongli Zhai; Yong Yu; Xiaofang Wang; Zhigang Zhao; Hongliang Yang; Xianming Liu; Lanfang Li; Lihua Qiu; Zhengzi Qian; Huilai Zhang; Yafei Wang; Haifeng Zhao
Journal:  Oncol Lett       Date:  2020-03-10       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.